PRISM-DR: Per-lesion Retinal Inference with Specialist Models for Diabetic Retinopathy

· Source: cs.CV updates on arXiv.org · Field: Science & Research — Health & Medical Research, Mathematics & Computational Sciences, Engineering & Applied Sciences · Depth: Expert, extended

Summary

PRISM-DR, a lesion-specific pipeline, addresses the challenge of detecting four non-proliferative diabetic retinopathy (DR) lesions—microaneurysms (MA), hemorrhages (HE), hard exudates (EX), and soft exudates (SE)—which often differ sharply in size, color, morphology, and prevalence. Unlike conventional multi-class models that favor common lesions, PRISM-DR employs a separate single-class YOLO detector for each lesion, allowing for individual configuration optimization. The system integrates region of interest (ROI) cropping, fundus-specific preprocessing, parallel YOLO detectors, tiling (for MA, HE, EX), per-lesion ensembling of five cross-validation folds, and an inter-lesion suppression step based on physical size and clinical priority. Trained on IDRiD with stratified five-fold cross-validation, PRISM-DR achieved a test mAP50 of 0.527 and an F1 score of 0.529, with hard exudates showing the highest AP50 at 0.561. The models demonstrated good transferability to e-ophtha (0.483 mAP50) without fine-tuning when imaging scales were similar to IDRiD, but performance degraded on DDR (0.159 mAP50) and TJDR (0.267 mAP50) due to greater variations in field of view and resolution.

Key takeaway

For Machine Learning Engineers developing medical image analysis systems, if you are building detectors for multiple, diverse lesion types, consider adopting a per-lesion model approach. This strategy, demonstrated by PRISM-DR, allows for tailored optimization of architecture, augmentation, and tiling for each lesion, improving overall detection accuracy, especially for small, hard-to-detect lesions like microaneurysms. You should also integrate clinical knowledge into post-processing steps, such as inter-lesion suppression, to resolve overlaps effectively.

Key insights

Treating each diabetic retinopathy lesion as an independent detection problem significantly improves accuracy over single multi-class models.

Principles

Method

PRISM-DR uses parallel YOLO detectors, each optimized for a specific DR lesion, with ROI cropping, preprocessing, tiling, Bayesian-tuned augmentation, five-fold ensembling, and clinical-priority-based inter-lesion suppression.

In practice

Topics

Code references

Best for: Computer Vision Engineer, AI Scientist, Machine Learning Engineer, Research Scientist

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by cs.CV updates on arXiv.org.